Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
ArrowMark Colorado Holdings LLC Has $106.96 Million Stake in AxoGen, Inc (NASDAQ:AXGN)
09:38am, Wednesday, 18'th Mar 2020
ArrowMark Colorado Holdings LLC grew its holdings in shares of AxoGen, Inc (NASDAQ:AXGN) by 11.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exc
Charles Schwab Investment Management Inc. Grows Stake in AxoGen, Inc (NASDAQ:AXGN)
10:14am, Sunday, 15'th Mar 2020
Charles Schwab Investment Management Inc. increased its holdings in shares of AxoGen, Inc (NASDAQ:AXGN) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and
AxoGen, Inc (NASDAQ:AXGN) Expected to Announce Earnings of -$0.14 Per Share
09:03am, Friday, 13'th Mar 2020
Wall Street brokerages expect AxoGen, Inc (NASDAQ:AXGN) to report ($0.14) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for
Barclays PLC Purchases 15,450 Shares of AxoGen, Inc (NASDAQ:AXGN)
08:26am, Friday, 13'th Mar 2020
Barclays PLC increased its position in AxoGen, Inc (NASDAQ:AXGN) by 56.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 42,748 shares of the medical equipmen
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
AxoGen trading halted, volatility trading pause AXGN
02:16pm, Thursday, 12'th Mar 2020
AxoGen trading halted, volatility trading pause AXGN
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Analysts Expect AxoGen, Inc (NASDAQ:AXGN) Will Announce Quarterly Sales of $27.05 Million
06:28am, Thursday, 12'th Mar 2020
Analysts expect AxoGen, Inc (NASDAQ:AXGN) to post sales of $27.05 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for AxoGen’s ea
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Stocks That Hit 52-Week Lows On Wednesday
03:41pm, Wednesday, 11'th Mar 2020
During Wednesday's morning session, 690 stocks hit new 52-week lows.
Intriguing Points:
Boeing (NYSE: BA) was the biggest company on a market cap basis to set a new...
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu
Bank of Montreal Can Has $3.04 Million Position in AxoGen, Inc (NASDAQ:AXGN)
08:38am, Monday, 09'th Mar 2020
Bank of Montreal Can boosted its holdings in shares of AxoGen, Inc (NASDAQ:AXGN) by 154.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and E
AxoGen (NASDAQ:AXGN) Raised to "Strong-Buy" at ValuEngine
10:50am, Saturday, 07'th Mar 2020
ValuEngine upgraded shares of AxoGen (NASDAQ:AXGN) from a buy rating to a strong-buy rating in a report released on Tuesday, ValuEngine reports. A number of other equities research analysts have also
